← Leaderboards
Neil Mukund Iyengar
Sloan-Kettering Inst Can Research
$5,144,285
Attributed
$6,909,123
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2019–24$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,909,123 · 2
By mechanism
R01$6,909,123 · 2
Top collaborators
- Lawrence H Kushi4 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Craig B Thompson$56,520,903
- Jason S Lewis$26,024,327
- Milind Rajadhyaksha$15,078,152
- Deborah Schrag$8,079,366
- Samuel Singer$8,089,401
Others in their field
Other Emerging Leaders on “Grant”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$208,271,537
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
- Julie Brisset · The University Of Central Florida Board Of Trustees$41,275,036
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
GrantImageEnrollmentStructurePlasmaInnovationMalignant Breast NeoplasmWomanPatient-Focused OutcomesReportingCohortPostmenopausePathway InteractionsMalignant NeoplasmsBreast Cancer ProgressionBaseCommon Terminology Criteria For Adverse EventsAppropriate DoseCostAntitumor EffectAntiestrogen TherapyAerobic ExerciseDoseChronic
Grant awards (9)
Breast White Adipose Tissue Inflammation and Breast Cancer Outcomes$710,316
R01 · FY2024 · CA
Breast White Adipose Tissue Inflammation and Breast Cancer Outcomes$920,624
R01 · FY2023 · CA
Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer$657,801
R01 · FY2023 · CA · contact PI
Breast White Adipose Tissue Inflammation and Breast Cancer Outcomes$926,607
R01 · FY2022 · CA
Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer$664,828
R01 · FY2022 · CA · contact PI
Breast White Adipose Tissue Inflammation and Breast Cancer Outcomes$972,130
R01 · FY2021 · CA
Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer$668,132
R01 · FY2021 · CA · contact PI
Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer$694,317
R01 · FY2020 · CA · contact PI
Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer$694,368
R01 · FY2019 · CA · contact PI